IRADIMED CORPORATION IRADIMED CORPORATION to Hold 2015 Fourth Quarter Financial Results Conference Call on February 5th
Winter Springs, Florida, January 22, 2016 - IRADIMEDCORPORATION(NASDAQ:IRMD) announced today that the Company will release its 2015 fourth quarter financial results before the market opens on Friday, February 5th. IRADIMEDmanagement will host a conference call the same day beginning at 11:00
a.m. Eastern Time to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering reservation code 37106645.
The conference call will also be available real-time via the Internet at www.iradimed.com/en-us/investors/index.phpand selecting Events & Presentations. A recording of the call will be available on the Company's website for 90 days following completion of the call.
IRADIMED CORPORATION is the only known provider of non-magnetic intravenous ("IV") infusion pump systems that are specifically designed to be safe for use during magnetic resonance imaging ("MRI") procedures. We were the first to develop an infusion delivery system that neutralizes the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency ("RF") interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our MRidium MRI compatible IV infusion pump system has been designed with a patented non-magnetic ultrasonic motor, uniquely-designed non- ferrous parts and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated in order to remain immobile during an MRI scan.
Media Contact: Chris Scott
Chief Financial Officer IRADIMEDCORPORATION(407) 677-8022
InvestorRelations@iradimed.com
IRadimed Corporation issued this content on 2016-01-22 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-25 08:23:02 UTC
Original Document: http://www.iradimed.com/en-us/pressRelease/2016/Q4_2015_Earnings_Announcement_Date.pdf
